Thioredoxin 1-mediated post-translational modifications: Reduction, transnitrosylation, denitrosylation, and related proteomics methodologies

Antioxidants and Redox Signaling

Volumn 15, Issue 9, 2011, Pages 2565-2604

  Wu, Changgong ^a   Parrott, Andrew M ^a   Fu, Cexiong ^b   Liu, Tong ^a   Marino, Stefano M ^c   Gladyshev, Vadim N ^c   Jain, Mohit R ^a   Baykal, Ahmet T ^d   Li, Qing ^a   Oka, Shinichi ^e   Sadoshima, Junichi ^e   Beuve, Annie ^a   Simmons, William J ^f   Li, Hong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MATERIALS INSTITUTE   (Turkey)

^e Cardiovascular Research Institute   (United States)

^f Sughrue Mion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIREDOXIN 1; THIOREDOXIN 1;

AMINO ACID SEQUENCE; CHEMICAL MODIFICATION; DENITROSYLATION; DISULFIDE BOND; GENETIC TRANSCRIPTION; HUMAN; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEOMICS; REDUCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSNITROSYLATION; UNINDEXED SEQUENCE;

ANIMALS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; THIOREDOXINS;

EID: 80053005317     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3831     Document Type: Review

References (284)

1. Abbas K, Breton J, and Drapier JC. The interplay between nitric oxide and peroxiredoxins. Immunobiology 213: 815-822, 2008.
2. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, and Cohen RA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 279: 29857-29862, 2004. (Pubitemid 38915870)
3. Ago T, Liu T, Zhai P, Chen W, Li H, Molkentin JD, Vatner SF, and Sadoshima J. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133: 978-993, 2008. (Pubitemid 351787743)
4. Ago T and Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal 9: 679-687, 2007. (Pubitemid 46799100)
5. Akamatsu Y, Ohno T, Hirota K, Kagoshima H, Yodoi J, and Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J Biol Chem 272: 14497-14500, 1997. (Pubitemid 27251706)
6. Aracena P, Tang W, Hamilton SL, and Hidalgo C. Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels. Antioxid Redox Signal 7: 870-881, 2005. (Pubitemid 40967138)
7. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
8. Arner ES and Holmgren A, The thioredoxin system in cancer. Semin Cancer Biol 16: 420-426, 2006. (Pubitemid 44780139)
9. Arnold WP, Mittal CK, Katsuki S, and Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3¢:5¢-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74: 3203-3207, 1977. (Pubitemid 8180317)
10. Aslund F, Berndt KD, and Holmgren A. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct proteinprotein redox equilibria. J Biol Chem 272: 30780-30786, 1997. (Pubitemid 27527515)
11. Atochina-Vasserman EN, Gow AJ, Abramova H, Guo CJ, Tomer Y, Preston AM, Beck JM, and Beers MF. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by Snitrosylation. J Immunol 182: 2277-2287, 2009.
12. Avval FZ and Holmgren A. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalians phase ribonucleotide reductase. J Biol Chem 284: 8233-8240, 2009.
13. Backs J and Olson EN. Control of cardiac growth by histone acetylation/deacetylation. Circ Res 98: 15-24, 2006. (Pubitemid 43977219)
14. Baker A, Payne CM, Briehl MM, and Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57: 5162-5167, 1997. (Pubitemid 27498136)
15. Balmer Y, Koller A, del Val G, Manieri W, Schurmann P, and Buchanan BB. Proteomics gives insight into the regulatory function of chloroplast thioredoxins. Proc Natl Acad Sci USA 100: 370-375, 2003. (Pubitemid 36078081)
16. Balmer Y, Vensel WH, Tanaka CK, Hurkman WJ, Gelhaye E, Rouhier N, Jacquot JP, Manieri W, Schurmann P, Droux M, and Buchanan BB. Thioredoxin links redox to the regulation of fundamental processes of plant mitochondria. Proc Natl Acad Sci USA 101: 2642-2647, 2004. (Pubitemid 38269364)
17. Barone E, Trombino S, Cassano R, Sgambato A, De Paola B, Di Stasio E, Picci N, Preziosi P, and Mancuso C. Characterization of the S-denitrosylating activity of bilirubin. J Cell Mol Med 13: 2365-2375, 2009.
18. Basu S, Grubina R, Huang J, Conradie J, Huang Z, Jeffers A, Jiang A, He X, Azarov I, Seibert R, Mehta A, Patel R, King SB, Hogg N, Ghosh A, Gladwin MT, and Kim-Shapiro DB. Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol 3: 785-794, 2007. (Pubitemid 350126874)
19. Baty JW, Hampton MB, and Winterbourn CC. Detection of oxidant sensitive thiol proteins by fluorescence labeling and two-dimensional electrophoresis. Proteomics 2: 1261-1266, 2002.
20. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
21. Benhar M, Forrester MT, Hess DT, and Stamler JS. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320: 1050-1054, 2008. (Pubitemid 351929542)
22. Benhar M, Forrester MT, and Stamler JS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10: 721-732, 2009.
23. Benhar M, Thompson JW, Moseley MA, and Stamler JS. Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. Biochemistry 49: 6963-6969, 2010.
24. Bennett CF, Balcarek JM, Varrichio A, and Crooke ST. Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature 334: 268-270, 1988.
25. Bentz BG, Simmons RL, Haines GK 3rd, and Radosevich JA. The yin and yang of nitric oxide: reflections on the physiology and pathophysiology of NO. Head Neck 22: 71-83, 2000. (Pubitemid 30030672)
26. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Herzenberg LA, Herzenberg LA, and Ghezzi P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J ExpMed 189: 1783-1789, 1999. (Pubitemid 29272695)
27. Bloomfield KL, Osborne SA, Kennedy DD, Clarke FM, and Tonissen KF. Thioredoxin-mediated redox control of the transcription factor Sp1 and regulation of the thioredoxin gene promoter. Gene 319: 107-116, 2003. (Pubitemid 37346205)
28. Bogumil R, Namgaladze D, Schaarschmidt D, Schmachtel T, Hellstern S, Mutzel R, and Ullrich V. Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide. Evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur J Biochem 267: 1407-1415, 2000. (Pubitemid 30143279)
29. Brennan JP, Wait R, Begum S, Bell JR, Dunn MJ, and Eaton P. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem 279: 41352-41360, 2004. (Pubitemid 39313574)
30. Broillet MC and Firestein S. Beta subunits of the olfactory cyclic nucleotide-gated channel form a nitric oxide activated Ca2 + channel. Neuron 18: 951-958, 1997. (Pubitemid 27274613)
31. Bruick RK and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340, 2001. (Pubitemid 33063099)
32. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, and Butterfield DA. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal 11: 2717-2739, 2009.
33. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, and Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8: 766-775, 2007. (Pubitemid 47462116)
34. Camerini S, Polci ML, Restuccia U, Usuelli V, Malgaroli A, and Bachi A. A novel approach to identify proteins modified by nitric oxide: the HIS-TAG switch method. J Proteome Res 6: 3224-3231, 2007. (Pubitemid 47310207)
35. Carvalho AP, Fernandes PA, and Ramos MJ. Similarities and differences in the thioredoxin superfamily. Prog Biophys Mol Biol 91: 229-248, 2006.
36. Carvalho AT, Fernandes PA, Swart M, Van Stralen JN, Bickelhaupt FM, and Ramos MJ. Role of the variable active site residues in the function of thioredoxin family oxidoreductases. J Comput Chem 30: 710-724, 2009.
37. Casagrande S, Bonetto V, Fratelli M, Gianazza E, Eberini I, Massignan T, Salmona M, Chang G, Holmgren A, and Ghezzi P. Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci USA 99: 9745-9749, 2002. (Pubitemid 34831118)
38. Cha MK and Kim IH. Disulfide between Cys392 and Cys438 of human serum albumin is redox-active, which is responsible for the thioredoxin-supported lipid peroxidase activity. Arch Biochem Biophys 445: 19-25, 2006.
39. Chae HZ, Kim HJ, Kang SW, and Rhee SG. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract 45: 101-112, 1999. (Pubitemid 29457756)
40. Chai YC, Jung CH, Lii CK, Ashraf SS, Hendrich S, Wolf B, Sies H, and Thomas JA. Identification of an abundant Sthiolated rat liver protein as carbonic anhydrase III; characterization of S-thiolation and dethiolation reactions. Arch Biochem Biophys 284: 270-278, 1991.
41. Chen CY, Willard D, and Rudolph J. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. Biochemistry 48: 1399-1409, 2009.
42. Chen YJ, Ku WC, Lin PY, Chou HC, and Khoo KH. Salkylating labeling strategy for site-specific identification of the s-nitrosoproteome. J Proteome Res 9: 6417-6439, 2010.
43. Chen YY, Chu HM, Pan KT, Teng CH, Wang DL, Wang AH, Khoo KH, and Meng TC. Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidationinduced permanent inactivation. J Biol Chem 283: 35265-35272, 2008.
44. Chevion M, Berenshtein E, and Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 33 Suppl: S99-S108, 2000. (Pubitemid 32055069)
45. Chiueh CC and Rauhala P. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic Res 31: 641-650, 1999.
46. Choi HI, Lee SP, Kim KS, Hwang CY, Lee YR, Chae SK, Kim YS, Chae HZ, and Kwon KS. Redox-regulated cochaperone activity of the human DnaJ homolog Hdj2. Free Radic Biol Med 40: 651-659, 2006. (Pubitemid 43170817)
47. Choi YB, Tenneti L, LeDA,Ortiz J, BaiG,ChenHS, and Lipton SA. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 3: 15-21, 2000. (Pubitemid 30126343)
48. Chouchani ET, Hurd TR, Nadtochiy SM, Brookes PS, Fearnley IM, Lilley KS, Smith RA, and Murphy MP. Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J 430: 49-59, 2010.
49. Chu K, Vojtchovsky J, McMahon BH, Sweet RM, Berendzen J, and Schlichting I. Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin. Nature 403: 921-923, 2000. (Pubitemid 30130998)
50. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, and Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279: 21749-21758, 2004. (Pubitemid 38679361)
51. D'Autreaux B and Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824, 2007. (Pubitemid 47462134)
52. DeMorrow S, Francis H, Gaudio E, Ueno Y, Venter J, Onori P, Franchitto A, Vaculin B, Vaculin S, and Alpini G. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol 294: G506-G519, 2008. (Pubitemid 351253342)
53. de Pina MZ, Vazquez-Meza H, Pardo JP, Rendon JL, Villalobos-Molina R, Riveros-Rosas H, and Pina E. Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin. J Biol Chem 283: 12373-12386, 2008.
54. Derakhshan B, Hao G, and Gross SS. Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc Res 75: 210-219, 2007. (Pubitemid 46961931)
55. Diet A, Abbas K, Bouton C, Guillon B, Tomasello F, Fourquet S, Toledano MB, and Drapier JC. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem 282: 36199-36205, 2007.
56. Dunn LL, Buckle AM, Cooke JP, and Ng MK. The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol 30: 2089-2098, 2010.
57. Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, and Grimm EA. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6: 4768-4775, 2000. (Pubitemid 32110418)
58. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, and Fujii-Kuriyama Y.Molecular mechanisms of transcription activation by HLF and HIF1 alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18: 1905-1914, 1999. (Pubitemid 29158534)
59. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, and Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001. (Pubitemid 32972036)
60. Erwin PA, Lin AJ, Golan DE, and Michel T. Receptorregulated dynamic S-nitrosylation of endothelial nitricoxide synthase in vascular endothelial cells. J Biol Chem 280: 19888-19894, 2005. (Pubitemid 41379517)
61. Erwin PA, Mitchell DA, Sartoretto J, Marletta MA, and Michel T. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem 281: 151-157, 2006. (Pubitemid 43671173)
62. Essex DW, Li M, Miller A, and Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry 40: 6070-6075, 2001. (Pubitemid 32466310)
63. Eu JP, Sun J, Xu L, Stamler JS, and Meissner G. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell 102: 499-509, 2000.
64. Fang J and Holmgren A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 128: 1879-1885, 2006. (Pubitemid 43277327)
65. Fang J, Nakamura T, Cho DH, Gu Z, and Lipton SA. Snitrosylation of peroxiredoxin 2 promotes oxidative stressinduced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci USA 104: 18742-18747, 2007. (Pubitemid 350210767)
66. Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, and Snyder SH. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28: 183-193, 2000.
67. Foglio MH and Duester G. Characterization of the functional gene encoding mouse class III alcohol dehydrogenase (glutathione-dependent formaldehyde dehydrogenase) and an unexpressed processed pseudogene with an intact open reading frame. Eur J Biochem 237: 496-504, 1996.
68. Foloppe N and Nilsson L. The glutaredoxin-C-P-Y-Cmotif: influence of peripheral residues. Structure 12: 289-300, 2004.
69. Foloppe N, Sagemark J, Nordstrand K, Berndt KD, and Nilsson L. Structure, dynamics and electrostatics of the active site of glutaredoxin 3 from Escherichia coli: comparison with functionally related proteins. J Mol Biol 310: 449-470, 2001. (Pubitemid 32664879)
70. Fomenko DE and Gladyshev VN. Identity and functions of CxxC-derived motifs. Biochemistry 42: 11214-11225, 2003. (Pubitemid 37158888)
71. Forrester MT, Seth D, Hausladen A, Eyler CE, Foster MW, Matsumoto A, Benhar M, Marshall HE, and Stamler JS. Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation. J Biol Chem 284: 36160-36166, 2009.
72. Forrester MT, Thompson JW, Foster MW, Nogueira L, Moseley MA, and Stamler JS. Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol 27: 557-559, 2009.
73. Foster MW, Hess DT, and Stamler JS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med 15: 391-404, 2009.
74. Fu C, Hu J, Liu T, Ago T, Sadoshima J, and Li H. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res 7: 3789-3802, 2008.
75. Fu C, Wu C, Liu T, Ago T, Zhai P, Sadoshima J, and Li H. Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics 8: 1674-1687, 2009.
76. Fujii J and Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130, 2002. (Pubitemid 34700435)
77. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, and Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res 56: 5765-5770, 1996. (Pubitemid 26422186)
78. Gallogly MM and Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381-391, 2007. (Pubitemid 47304000)
79. Gallogly MM, Starke DW, and Mieyal JJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal 11: 1059-1081, 2009.
80. Gasdaska JR, Kirkpatrick DL, Montfort W, Kuperus M, Hill SR, Berggren M, and Powis G. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73->Ser mutation. Biochem Pharmacol 52: 1741-1747, 1996. (Pubitemid 26407990)
81. Gaston BM, Carver J, Doctor A, and Palmer LA. S-nitrosylation signaling in cell biology. Mol Interv 3: 253-263, 2003.
82. Go YM, Halvey PJ, Hansen JM, Reed M, Pohl J, and Jones DP. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 171: 1670-1681, 2007. (Pubitemid 350158327)
83. Godoy L, Gonzalez-Duarte R, and Albalat R. S-nitrosogluthathione reductase activity of amphioxus ADH3: insights into the nitric oxide metabolism. Int J Biol Sci 2: 117-124, 2006. (Pubitemid 43793977)
84. Gorman JJ, Wallis TP, and Pitt JJ. Protein disulfide bond determination by mass spectrometry. Mass Spectrom Rev 21: 183-216, 2002.
85. Greco TM, Hodara R, Parastatidis I, Heijnen HF, Dennehy MK, Liebler DC, and Ischiropoulos H. Identification of Snitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci USA 103: 7420-7425, 2006. (Pubitemid 43727848)
86. Guo Y, Einhorn L, Kelley M, Hirota K, Yodoi J, Reinbold R, Scholer H, Ramsey H, and Hromas R. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin. Stem Cells 22: 259-264, 2004. (Pubitemid 38736610)
87. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999. (Pubitemid 29474856)
88. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine. Nat Cell Biol 4: 743-749, 2002. (Pubitemid 35214767)
89. Haendeler J, Hoffmann J, Zeiher AM, and Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 110: 856-861, 2004. (Pubitemid 39096015)
90. Hagglund P, Bunkenborg J, Maeda K, and Svensson B. Identification of thioredoxin disulfide targets using a quantitative proteomics approach based on isotope-coded affinity tags. J Proteome Res 7: 5270-5276, 2008.
91. Hall A, Karplus PA, and Poole LB. Typical 2-Cys peroxiredoxins- structures, mechanisms and functions. FEBS J 276: 2469-2477, 2009.
92. Han S. Force field parameters for S-nitrosocysteine and molecular dynamics simulations of S-nitrosated thioredoxin. Biochem Biophys Res Commun 377: 612-616, 2008.
93. Hansen JM, Watson WH, and Jones DP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 82: 308-317, 2004. (Pubitemid 39485343)
94. Hansen RE and Winther JR. An introduction to methods for analyzing thiols and disulfides: reactions, reagents, and practical considerations. Anal Biochem 394: 147-158, 2009.
95. Hao G, Derakhshan B, Shi L, Campagne F, and Gross SS. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci USA 103: 1012-1017, 2006. (Pubitemid 43212213)
96. Hashemy SI and Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem 283: 21890-21898, 2008.
97. Haugstetter J, Blicher T, and Ellgaard L. Identification and characterization of a novel thioredoxin-related transmembrane protein of the endoplasmic reticulum. J Biol Chem 280: 8371-8380, 2005. (Pubitemid 40349741)
98. Hayashi S, Hajiro-Nakanishi K, Makino Y, Eguchi H, Yodoi J, and Tanaka H. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res 25: 4035-4040, 1997. (Pubitemid 27443331)
99. Held JM, Danielson SR, Behring JB, Atsriku C, Britton DJ, Puckett RL, Schilling B, Campisi J, Benz CC, and Gibson BW. Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approach. Mol Cell Proteomics 9: 1400-1410, 2010.
100. Hess DT, Matsumoto A, Kim SO, Marshall HE, and Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6: 150-166, 2005. (Pubitemid 40215810)
101. Hess DT, Matsumoto A, Nudelman R, and Stamler JS. Snitrosylation: spectrum and specificity. Nat Cell Biol 3: E46-E49, 2001.
102. Hidalgo C, Donoso P, and Carrasco MA. The ryanodine receptors Ca2 + release channels: cellular redox sensors? IUBMB Life 57: 315-322, 2005. (Pubitemid 40904260)
103. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638, 1997. (Pubitemid 27180424)
104. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897, 1999.
105. Hoffman MD, Walsh GM, Rogalski JC, and Kast J. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics 8: 887-903, 2009.
106. Holmgren A. Enzymatic reduction-oxidation of protein disulfides by thioredoxin. Methods Enzymol 107: 295-300, 1984.
107. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985. (Pubitemid 15073647)
108. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem 254: 9627-9632, 1979. (Pubitemid 10248727)
109. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989. (Pubitemid 19214215)
110. Holmgren A and Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 396: 120-124, 2010.
111. Huang Y, Man HY, Sekine-Aizawa Y, Han Y, Juluri K, Luo H, Cheah J, Lowenstein C, Huganir RL, and Snyder SH. Snitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron 46: 533-540, 2005. (Pubitemid 40797379)
112. Hurd TR, Prime TA, Harbour ME, Lilley KS, and Murphy MP. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: implications for mitochondrial redox signaling. J Biol Chem 282: 22040-22051, 2007. (Pubitemid 47195755)
113. Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, and Kwon KS. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene 23: 8868-8875, 2004. (Pubitemid 39657777)
114. Ibiza S, Perez-Rodriguez A, Ortega A, Martinez-Ruiz A, Barreiro O, Garcia-Dominguez CA, Victor VM, Esplugues JV, Rojas JM, Sanchez-Madrid F, and Serrador JM. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci USA 105: 10507-10512, 2008.
115. Inomata Y, Tanihara H, Tanito M, Okuyama H, Hoshino Y, Kinumi T, Kawaji T, Kondo N, Yodoi J, and Nakamura H. Suppression of choroidal neovascularization by thioredoxin-1 via interaction with complement factor H. Invest Ophthalmol Vis Sci 49: 5118-5125, 2008.
116. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 305: 776-783, 2003. (Pubitemid 36581936)
117. Jacquier-Sarlin MR and Polla BS. Dual regulation of heatshock transcription factor (HSF) activation and DNAbinding activity by H2O2: role of thioredoxin. Biochem J 318 (Pt 1): 187-193, 1996. (Pubitemid 26283644)
118. Jaffrey SR and Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: pl1, 2001.
119. Jeong W, Yoon HW, Lee SR, and Rhee SG. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function. J Biol Chem 279: 3142-3150, 2004. (Pubitemid 38140546)
120. Ji Y, Akerboom TP, Sies H, and Thomas JA. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 362: 67-78, 1999. (Pubitemid 29391652)
121. Kahlos K, Zhang J, Block ER, and Patel JM. Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem 254: 47-54, 2003. (Pubitemid 37483738)
122. Kallis GB and Holmgren A. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J Biol Chem 255: 10261-10265, 1980. (Pubitemid 11214607)
123. Kang SW, Chae HZ, SeoMS, KimK, Baines IC, and Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273: 6297-6302, 1998. (Pubitemid 28144719)
124. Keszler A, Zhang Y, and Hogg N. Reaction between nitric oxide, glutathione, and oxygen in the presence and absence of protein: how are S-nitrosothiols formed? Free Radic Biol Med 48: 55-64, 2010.
125. Kim HY and Kim JR. Thioredoxin as a reducing agent for mammalian methionine sulfoxide reductases B lacking resolving cysteine. Biochem Biophys Res Commun 371: 490-494, 2008.
126. Kim JR, Yoon HW, Kwon KS, Lee SR, and Rhee SG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem 283: 214-221, 2000. (Pubitemid 30626272)
127. Kim YM, Talanian RV, and Billiar TR. Nitric oxide inhibits apoptosis bypreventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272: 31138-31148, 1997. (Pubitemid 27527564)
128. Kirkpatrick L, Dragovich T, Ramanathan R, Sharlow E, Chow S, Williams D, Himler R, Baker A, and Egorin M. Results from Phase I study of PX-12, a thioredoxin inhibitor in patients with advanced solid malignancies. J Clin Oncol 22: 3089, 2004.
129. Kornberg MD, Sen N, Hara MR, Juluri KR, Nguyen JV, Snowman AM, Law L, Hester LD, and Snyder SH. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol 12: 1094-1100, 2010.
130. Krause G, Lundstrom J, Barea JL, Pueyo de la Cuesta C, and Holmgren A. Mimicking the active site of protein disulfide-isomerase by substitution of proline 34 in Escherichia coli thioredoxin. J Biol Chem 266: 9494-9500, 1991. (Pubitemid 21906684)
131. Kurooka H, Kato K, Minoguchi S, Takahashi Y, Ikeda J, Habu S, Osawa N, Buchberg AM, Moriwaki K, Shisa H, and Honjo T. Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics 39: 331-339, 1997. (Pubitemid 27078699)
132. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, Cohen RA, Liao R, Siwik DA, and Colucci WS. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111: 1192-1198, 2005. (Pubitemid 40365482)
133. Kwon M, Yoon CS, Jeong W, Rhee SG, and Waisman DM. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J Biol Chem 280: 23584-23592, 2005. (Pubitemid 40884837)
134. Lancaster JR Jr. and Gaston B. NO and nitrosothiols: spatial confinement and free diffusion. Am J Physiol Lung Cell Mol Physiol 287: L465-L466, 2004. (Pubitemid 39095898)
135. Lander HM, Milbank AJ, Tauras JM, Hajjar DP, Hempstead BL, Schwartz GD, Kraemer RT, Mirza UA, Chait BT, Burk SC, and Quilliam LA. Redox regulation of cell signalling. Nature 381: 380-381, 1996. (Pubitemid 126515840)
136. Lane P, Hao G, and Gross SS. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE 2001: re1, 2001.
137. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998. (Pubitemid 28298140)
138. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, and Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002. (Pubitemid 34967328)
139. Lee W, Choi KS, Riddell J, Ip C, Ghosh D, Park JH, and Park YM. Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem 282: 22011-22022, 2007. (Pubitemid 47195750)
140. Lefievre L, Chen Y, Conner SJ, Scott JL, Publicover SJ, Ford WC, and Barratt CL. Human spermatozoa contain multiple targets for protein S-nitrosylation: an alternative mechanism of the modulation of sperm function by nitric oxide? Proteomics 7: 3066-3084, 2007. (Pubitemid 47477951)
141. Leichert LI, Gehrke F, Gudiseva HV, Blackwell T, Ilbert M, Walker AK, Strahler JR, Andrews PC, and Jakob U. Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci USA 105: 8197-8202, 2008. (Pubitemid 351904734)
142. Lewin A, Crow A, Oubrie A, and Le Brun NE. Molecular basis for specificity of the extracytoplasmic thioredoxin ResA. J Biol Chem 281: 35467-35477, 2006. (Pubitemid 46036583)
143. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, Vujaskovic Z, Dewhirst MW, and Li CY. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 26: 63-74, 2007. (Pubitemid 46550936)
144. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997. (Pubitemid 27523676)
145. Li Y, Liu W, Xing G, Tian C, Zhu Y, and He F. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB. Cell Signal 17: 985-996, 2005. (Pubitemid 40723587)
146. Lillig CH and Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid Redox Signal 9: 25-47, 2007. (Pubitemid 44901873)
147. Lim KH, Ancrile BB, Kashatus DF, and Counter CM. Tumour maintenance is mediated by eNOS. Nature 452: 646-649, 2008. (Pubitemid 351483359)
148. Lima B, Lam GK, Xie L, Diesen DL, Villamizar N, Nienaber J, Messina E, Bowles D, Kontos CD, Hare JM, Stamler JS, and Rockman HA. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci USA 106: 6297-6302, 2009.
149. Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, and Bankston LA. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci 25: 474-480, 2002. (Pubitemid 35223002)
150. Liu GH, Qu J, and Shen X. Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity. Mol Biol Cell 17: 1822-1833, 2006. (Pubitemid 44011598)
151. Liu X, Miller MJ, Joshi MS, Thomas DD, and Lancaster JR Jr. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 95: 2175-2179, 1998. (Pubitemid 28145914)
152. Liu Y and Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90: 1259-1266, 2002. (Pubitemid 34787407)
153. Lopez-Sanchez LM, Corrales FJ, Lopez-Pedrera C, Aranda E, and Rodriguez-Ariza A. Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells. Anticancer Res 30: 415-421, 2010.
154. Lovell MA, Xie C, Gabbita SP, and Markesbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28: 418-427, 2000. (Pubitemid 30110658)
155. Low FM, Hampton MB, Peskin AV, and Winterbourn CC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109: 2611-2617, 2007. (Pubitemid 46425910)
156. Lundstrom-Ljung J, Birnbach U, Rupp K, Soling HD, and Holmgren A. Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: comparison with protein disulfide isomerase. FEBS Lett 357: 305-308, 1995.
157. Maiorino M, Ursini F, Bosello V, Toppo S, Tosatto SC, Mauri P, Becker K, Roveri A, Bulato C, Benazzi L, De Palma A, and Flohe L. The thioredoxin specificity of Drosophila GPx: a paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases. J Mol Biol 365: 1033-1046, 2007. (Pubitemid 46014177)
158. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 274: 3182-3188, 1999. (Pubitemid 29075407)
159. Manabe S, Gu Z, and Lipton SA. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46: 4747-4753, 2005. (Pubitemid 44264580)
160. Mancuso C, Capone C, Ranieri SC, Fusco S, Calabrese V, Eboli ML, Preziosi P, Galeotti T, and Pani G. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res 86: 2235-2249, 2008.
161. Mancuso C, Navarra P, and Preziosi P. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary- adrenal axis. J Neurochem 113: 563-575, 2010.
162. Mannick JB. Regulation of apoptosis by protein S-nitrosylation. Amino Acids 32: 523-526, 2007. (Pubitemid 46790933)
163. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K, and Gaston B. S-nitrosylation of mitochondrial caspases. J Cell Biol 154: 1111-1116, 2001. (Pubitemid 34286189)
164. Marchand CH, Vanacker H, Collin V, Issakidis-Bourguet E, Marechal PL, and Decottignies P. Thioredoxin targets in Arabidopsis roots. Proteomics 10: 2418-2428, 2010.
165. Marino SM and Gladyshev VN. Redox biology: computational approaches to the investigation of functional cysteine residues. Antioxid Redox Signal 15:135-146, 2011.
166. Marino SM and Gladyshev VN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol 404: 902-916, 2010.
167. Marino SM and Gladyshev VN. Structural analysis of cysteine S-nitrosylation: a modified acid-based motif and the emerging role of trans-nitrosylation. J Mol Biol 395: 844-859, 2010.
168. Marshall HE and Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J Biol Chem 277: 34223-34228, 2002.
169. Martin JL. Thioredoxin-a fold for all reasons. Structure 3: 245-250, 1995.
170. Martinez-Ruiz A, Villanueva L, Gonzalez de Orduna C, Lopez-Ferrer D, Higueras MA, Tarin C, Rodriguez-Crespo I, Vazquez J, and Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci USA 102: 8525-8530, 2005. (Pubitemid 40862769)
171. Matsuo Y, Akiyama N, Nakamura H, Yodoi J, Noda M, and Kizaka-Kondoh S, Identification of a novel thioredoxin-related transmembrane protein. J Biol Chem 276: 10032-10038, 2001.
172. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, and Hay RT. Thioredoxin regulates the DNA binding activity of NFkappa B by reduction of a disulphide bond involving cysteine. Nucleic Acids Res 20: 3821-3830, 1992.
173. Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, Donoghue N, and Hogg PJ. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 3: 727-732, 2002.
174. McCarthy SM, Bove PF, Matthews DE, Akaike T, and van der Vliet A. Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. Biochemistry 47: 5832-5840, 2008. (Pubitemid 351747062)
175. McDonagh B, Ogueta S, Lasarte G, Padilla CA, and Barcena JA. Shotgun redox proteomics identifies specifically modified cysteines in key metabolic enzymes under oxidative stress in Saccharomyces cerevisiae. J Proteomics 72: 677-689, 2009.
176. McKinsey TA, Zhang CL, Lu J, and Olson EN. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408: 106-111, 2000.
177. Melchers J, Dirdjaja N, Ruppert T, and Krauth-Siegel RL. Glutathionylation of trypanosomal thiol redox proteins. J Biol Chem 282: 8678-8694, 2007. (Pubitemid 47093487)
178. Melikian N, Seddon MD, Casadei B, Chowienczyk PJ, and Shah AM. Neuronal nitric oxide synthase and human vascular regulation. Trends CardiovascMed 19: 256-262, 2009.
179. Meuillet EJ, Mahadevan D, Berggren M, Coon A, and Powis G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429: 123-133, 2004. (Pubitemid 39093822)
180. Michelet L, Zaffagnini M, Marchand C, Collin V, Decottignies P, Tsan P, Lancelin JM, Trost P, Miginiac-Maslow M, Noctor G, and Lemaire SD. Glutathionylation of chloroplast thioredoxin f is a redox signaling mechanism in plants. Proc Natl Acad Sci USA 102: 16478-16483, 2005. (Pubitemid 41688939)
181. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, and Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988, 2008.
182. Minetti M, Mallozzi C, Di Stasi AM, and Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352: 165-174, 1998. (Pubitemid 28368581)
183. Mitchell DA, Erwin PA, Michel T, and Marletta MA. Snitrosation and regulation of inducible nitric oxide synthase. Biochemistry 44: 4636-4647, 2005. (Pubitemid 40396742)
184. Mitchell DA and Marletta MA. Thioredoxin catalyzes the Snitrosation of the caspase-3 active site cysteine. Nat Chem Biol 1: 154-158, 2005.
185. Mitchell DA, Morton SU, Fernhoff NB, and Marletta MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc Natl Acad Sci USA 104: 11609-11614, 2007. (Pubitemid 47175060)
186. Mohr S, Hallak H, de Boitte A, Lapetina EG, and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274: 9427-9430, 1999.
187. Motohashi K, Kondoh A, Stumpp MT, and Hisabori T. Comprehensive survey of proteins targeted by chloroplast thioredoxin. Proc Natl Acad Sci USA 98: 11224-11229, 2001. (Pubitemid 32928710)
188. Musiani F, Ciurli S, and Dikiy A. The interaction of selenoprotein W with 14-3-3 proteins: a computational approach. J Proteome Res 10: 968-976, 2011.
189. Nadeau PJ, Charette SJ, Toledano MB, and Landry J. Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H2O2-induced c-Jun NH2-terminal kinase activation and apoptosis. Mol Biol Cell 18: 3903-3913, 2007. (Pubitemid 47519483)
190. Nagahara N, Yoshii T, Abe Y, and Matsumura T. Thioredoxin-dependent enzymatic activation of mercaptopyruvate sulfurtransferase. An intersubunit disulfide bond serves as a redox switch for activation. J Biol Chem 282: 1561-1569, 2007. (Pubitemid 47076697)
191. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997. (Pubitemid 27169285)
192. Nakamura T and Lipton SA. Emerging roles of Snitrosylation in protein misfolding and neurodegenerative diseases. Antioxid Redox Signal 10: 87-101, 2008. (Pubitemid 350115990)
193. Nakamura T, Wang L, Wong CC, Scott FL, Eckelman BP, Han X, Tzitzilonis C, Meng F, Gu Z, Holland EA, Clemente AT, Okamoto S, Salvesen GS, Riek R, Yates JR 3rd, and Lipton SA. Transnitrosylation of XIAP regulates caspasedependent neuronal cell death. Mol Cell 39: 184-195, 2010.
194. Nedospasov A, Rafikov R, Beda N, and Nudler E. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci USA 97: 13543-13548, 2000.
195. Nedospasov AA. Is N2O3 the main nitrosating intermediate in aerated nitric oxide (NO) solutions in vivo? If so, where, when, and which one? J Biochem Mol Toxicol 16: 109-120, 2002. (Pubitemid 34752480)
196. Nikitovic D and Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 271: 19180-19185, 1996. (Pubitemid 26271582)
197. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
198. Nordstrand K, slund, F, Holmgren A, Otting G, and Berndt KD. NMR structure of Escherichia coli glutaredoxin 3-glutathione mixed disulfide complex: implications for the enzymatic mechanism. J Mol Biol 286: 541-552, 1999. (Pubitemid 29090168)
199. Nott A, Watson PM, Robinson JD, Crepaldi L, and Riccio A. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455: 411-415, 2008.
200. Okado-Matsumoto A, Matsumoto A, Fujii J, and Taniguchi N. Peroxiredoxin IV is a secretable protein with heparinbinding properties under reduced conditions. J Biochem 127: 493-501, 2000. (Pubitemid 30185255)
201. Oliveira L, Bouton C, and Drapier JC. Thioredoxin activation of iron regulatory proteins. Redox regulation of RNA binding after exposure to nitric oxide. J Biol Chem 274: 516-521, 1999. (Pubitemid 29035091)
202. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, and Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386, 2002.
203. Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefkowitz RJ, and Stamler JS. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 31: 395-405, 2008.
204. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007. (Pubitemid 46217686)
205. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, and Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317: 799-804, 1987. (Pubitemid 17136471)
206. Palmer LA, Doctor A, Chhabra P, Sheram ML, Laubach VE, Karlinsey MZ, Forbes MS, Macdonald T, and Gaston B. Snitrosothiols signal hypoxia-mimetic vascular pathology. J Clin Invest 117: 2592-2601, 2007. (Pubitemid 47494360)
207. Pan S and Berk BC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death path way. Circ Res 100: 213-219, 2007. (Pubitemid 46208721)
208. Park HS, Yu JW, Cho JH, Kim MS, Huh SH, Ryoo K, and Choi EJ. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem 279: 7584-7590, 2004. (Pubitemid 38294637)
209. Patel JM, Zhang J, and Block ER. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol 15: 410-419, 1996. (Pubitemid 126439909)
210. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, and Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281: 21884-21891, 2006. (Pubitemid 44181892)
211. Pawloski JR, Hess DT, and Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature 409: 622-626, 2001. (Pubitemid 32154814)
212. Peng J, Elias JE, Thoreen CC, Licklider LJ, and Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2: 43-50, 2003. (Pubitemid 36207189)
213. Perez-Jimenez R, Li J, Kosuri P, Sanchez-Romero I, Wiita AP, Rodriguez-Larrea D, Chueca A, Holmgren A, Miranda-Vizuete A, Becker K, Cho SH, Beckwith J, Gelhaye E, Jacquot JP, Gaucher EA, Sanchez-Ruiz JM, Berne BJ, and Fernandez JM. Diversity of chemical mechanisms in thioredoxin catalysis revealed by single-molecule force spectroscopy. Nat Struct Mol Biol 16: 890-896, 2009.
214. Perez-Mato I, Castro C, Ruiz FA, Corrales FJ, and Mato JM. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J Biol Chem 274: 17075-17079, 1999.
215. Pimentel DR, Adachi T, Ido Y, Heibeck T, Jiang B, Lee Y, Melendez JA, Cohen RA, and Colucci WS. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol 41: 613-622, 2006. (Pubitemid 44374531)
216. Powis G, Mustacich D, and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312-322, 2000.
217. Qin J, Clore GM, Kennedy WM, Huth JR, and Gronenborn AM. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3: 289-297, 1995.
218. Ravi K, Brennan LA, Levic S, Ross PA, and Black SM. Snitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci USA 101: 2619-2624, 2004. (Pubitemid 38269360)
219. Reiter E and Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17: 159-165, 2006.
220. Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, Feelisch M, Fukuto J, and Wink DA. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 385: 1-10, 2004. (Pubitemid 38240288)
221. Roos G, Foloppe N, Van Laer K, Wyns L, Nilsson L, Geerlings P, and Messens J. How thioredoxin dissociates its mixed disulfide. PLoS Comput Biol 5: e1000461, 2009.
222. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, and Pappin DJ. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169, 2004.
223. Rossi R, Lusini L, Giannerini F, Giustarini D, Lungarella G, and Di Simplicio P. A method to study kinetics of transnitrosation with nitrosoglutathione: reactions with hemoglobin and other thiols. Anal Biochem 254: 215-220, 1997. (Pubitemid 28021082)
224. Rozell B, Hansson HA, Luthman M, and Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38: 79-86, 1985. (Pubitemid 15045722)
225. Sabens EA and Mieyal JJ. Glutaredoxin and thioredoxin enzyme systems: catalytic mechanisms and physiological functions. In: Glutathione and Sulfur Amino Acids in Human Health and Disease, edited by Masella R and Massa G. Hoboken, NJ: John Wiley & Sons, Inc., 2009, pp. 121-156.
226. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998. (Pubitemid 28221195)
227. Santhanam L, Lim HK, Miriel V, Brown T, Patel M, Balanson S, Ryoo S, Anderson M, Irani K, Khanday F, Di Costanzo L, Nyhan D, Hare JM, Christianson DW, Rivers R, Shoukas A, and Berkowitz DE. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 101: 692-702, 2007. (Pubitemid 47494100)
228. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001. (Pubitemid 32786086)
229. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83: 670-675, 1958.
230. Sayed N, Baskaran P, Ma X, van den Akker F, and Beuve A. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104: 12312-12317, 2007. (Pubitemid 47206134)
231. Sayed N, Kim DD, Fioramonti X, Iwahashi T, Duran WN, and Beuve A. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Circ Res 103: 606-614, 2008.
232. Schroeder P, Popp R, Wiegand B, Altschmied J, and Haendeler J. Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells-important role for nuclear thioredoxin-1. Arterioscler Thromb Vasc Biol 27: 2325-2331, 2007. (Pubitemid 350203946)
233. Schulze PC, Liu H, Choe E, Yoshioka J, Shalev A, Bloch KD, and Lee RT. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity. Arterioscler Thromb Vasc Biol 26: 2666-2672, 2006.
234. Schwarz O, Schurmann P, and Strotmann H. Kinetics and thioredoxin specificity of thiol modulation of the chloroplast H+-ATPase. J Biol Chem 272: 16924-16927, 1997. (Pubitemid 27289793)
235. Schwertassek U, Balmer Y, Gutscher M, Weingarten L, Preuss M, Engelhard J, Winkler M, and Dick TP. Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J 26: 3086-3097, 2007. (Pubitemid 47057486)
236. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N, Thomas B, Dawson TM, Dawson VL, Snyder SH, and Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 10: 866-873, 2008. (Pubitemid 351934066)
237. Sengupta R, Billiar TR, and Stoyanovsky DA. Studies toward the analysis of S-nitrosoproteins. Org Biomol Chem 7: 232-234, 2009.
238. Sengupta R, Ryter SW, Zuckerbraun BS, Tzeng E, Billiar TR, and Stoyanovsky DA. Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. Biochemistry 46: 8472-8483, 2007. (Pubitemid 47075984)
239. Seo MS, Kang SW, Kim K, Baines IC, Lee TH, and Rhee SG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346-20354, 2000. (Pubitemid 30457609)
240. Seth D and Rudolph J. Redox regulation of MAP kinase phosphatase 3. Biochemistry 45: 8476-8487, 2006. (Pubitemid 44078867)
241. Shioji K, Nakamura H, Masutani H, and Yodoi J. Redox regulation by thioredoxin in cardiovascular diseases. Antioxid Redox Signal 5: 795-802, 2003. (Pubitemid 37462063)
242. Sohn J and Rudolph J. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42: 10060-10070, 2003. (Pubitemid 37052026)
243. Stamler JS and Hess DT. Nascent nitrosylases. Nat Cell Biol 12: 1024-6, 2010.
244. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, and Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997. (Pubitemid 27443606)
245. Stamler JS, Lamas S, and Fang FC.Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106: 675-683, 2001. (Pubitemid 32900659)
246. Stamler JS and Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 81: 209-237, 2001. (Pubitemid 32096176)
247. Stoyanovsky DA, Tyurina YY, Tyurin VA, Anand D, Mandavia DN, Gius D, Ivanova J, Pitt B, Billiar TR, and Kagan VE. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 127: 15815-15823, 2005. (Pubitemid 41643291)
248. Stubauer G, Giuffre A, and Sarti P. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem 274: 28128-28133, 1999.
249. Sumbayev VV. S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1. Arch Biochem Biophys 415: 133-136, 2003. (Pubitemid 36687926)
250. Sun J. Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning. Sheng Li Xue Bao 59: 544-552, 2007.
251. Sun J, Morgan M, Shen RF, Steenbergen C, and Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 101: 1155-1163, 2007. (Pubitemid 350146442)
252. Sun J, Xin C, Eu JP, Stamler JS, andMeissnerG. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA 98: 11158-11162, 2001. (Pubitemid 32928699)
253. Tamura T and Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93: 1006-1011, 1996. (Pubitemid 26054364)
254. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, and Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002. (Pubitemid 34614625)
255. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, and Ma XL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation. Proc Natl Acad Sci USA 101: 11471-11476, 2004. (Pubitemid 39038371)
256. Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B, Christopher T, RamachandraRao SP, Williams W, Southan G, Sharma K, Koch W, and Ma XL. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 114: 1395-1402, 2006. (Pubitemid 44454559)
257. Tello D, Tarin C, Ahicart P, Breton-Romero R, Lamas S, and Martinez-Ruiz A. A "fluorescence switch" technique increases the sensitivity of proteomic detection and identification of S-nitrosylated proteins. Proteomics 9: 5359-5370, 2009.
258. Ueda S, Nakamura H, Masutani H, Sasada T, Yonehara S, Takabayashi A, Yamaoka Y, and Yodoi J. Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J Immunol 161: 6689-6695, 1998. (Pubitemid 28562211)
259. Vanin AF, Malenkova IV, and Serezhenkov VA. Iron catalyzes both decomposition and synthesis of S-nitrosothiols: optical and electron paramagnetic resonance studies. Nitric Oxide 1: 191-203, 1997. (Pubitemid 28079396)
260. Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, and Catravas JD. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 285: H669-H678, 2003. (Pubitemid 36885899)
261. Verdoucq L, Vignols F, Jacquot JP, Chartier Y, and Meyer Y. In vivo characterization of a thioredoxin h target protein defines a new peroxiredoxin family. J Biol Chem 274: 19714-19722, 1999.
262. Vieira Dos Santos C, Laugier E, Tarrago L, Massot V, Issakidis-Bourguet E, Rouhier N, and Rey P. Specificity of thioredoxins and glutaredoxins as electron donors to two distinct classes of Arabidopsis plastidial methionine sulfoxide reductases B. FEBS Lett 581: 4371-4376, 2007. (Pubitemid 47376692)
263. von Knethen A, Callsen D, and Brune B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 10: 361-372, 1999. (Pubitemid 29156478)
264. Wagner E, Luche S, Penna L, Chevallet M, Van Dorsselaer A, Leize-Wagner E, and Rabilloud T. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem J 366: 777-785, 2002.
265. Wang D, Masutani H, Oka S, Tanaka T, Yamaguchi-Iwai Y, Nakamura H, and Yodoi J. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J Biol Chem 281: 7384-7391, 2006. (Pubitemid 43847508)
266. Wang G, Moniri NH, Ozawa K, Stamler JS, and Daaka Y. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci USA 103: 1295-1300, 2006. (Pubitemid 43191159)
267. Wang Y, Liu T, Wu C, and Li H. A strategy for direct identification of protein S-nitrosylation sites by quadrupole time-of-flight mass spectrometry. J Am Soc Mass Spectrom 19: 1353-1360, 2008.
268. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, and Jones DP. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem 278: 33408-33415, 2003. (Pubitemid 37055794)
269. Weichsel A, Brailey JL, and Montfort WR. Buried S-nitrosocysteine revealed in crystal structures of human thioredoxin. Biochemistry 46: 1219-1227, 2007. (Pubitemid 46208470)
270. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, Koch WJ, Daaka Y, Lefkowitz RJ, and Stamler JS. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of Gprotein-coupled receptor kinase 2. Cell 129: 511-522, 2007. (Pubitemid 46660966)
271. Wiita AP, Perez-Jimenez R, Walther KA, Grater F, Berne BJ, Holmgren A, Sanchez-Ruiz JM, and Fernandez JM. Probing the chemistry of thioredoxin catalysis with force. Nature 450: 124-127, 2007. (Pubitemid 350070567)
272. Wong JH, Balmer Y, Cai N, Tanaka CK, Vensel WH, Hurkman WJ, and Buchanan BB. Unraveling thioredoxinlinked metabolic processes of cereal starchy endosperm using proteomics. FEBS Lett 547: 151-156, 2003. (Pubitemid 36829396)
273. Wu C, Liu T, Chen W, Oka S, Fu C, Jain MR, Parrott AM, Baykal AT, Sadoshima J, and Li H. Redox regulatory mechanism of transnitrosylation by thioredoxin. Mol Cell Proteomics 9: 2262-2275, 2010.
274. Xu SZ, Sukumar P, Zeng F, Li J, Jairaman A, English A, Naylor J, Ciurtin C, Majeed Y, Milligan CJ, Bahnasi YM, Al-Shawaf E, Porter KE, Jiang LH, Emery P, Sivaprasadarao A, and Beech DJ. TRPC channel activation by extracellular thioredoxin. Nature 451: 69-72, 2008.
275. Yamamoto M, Yang GP, Hong C, Liu J, Holle E, Yu XZ, Wagner T, Vatner SF, and Sadoshima J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112: 1395-1406, 2003. (Pubitemid 38057693)
276. Yamazaki D, Motohashi K, Kasama T, Hara Y, and Hisabori T. Target proteins of the cytosolic thioredoxins in Arabidopsis thaliana. Plant Cell Physiol 45: 18-27, 2004. (Pubitemid 38192330)
277. Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, and Rhee SG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem 277: 38029-38036, 2002. (Pubitemid 35154654)
278. Yano H, Wong JH, Lee YM, Cho MJ, and Buchanan BB. A strategy for the identification of proteins targeted by thioredoxin. Proc Natl Acad Sci USA 98: 4794-4799, 2001. (Pubitemid 32295055)
279. Yoshioka J, Schreiter ER, and Lee RT. Role of thioredoxin in cell growth through interactions with signaling molecules. Antioxid Redox Signal 8: 2143-2151, 2006. (Pubitemid 46489637)
280. Zhang H, Tao L, Jiao X, Gao E, Lopez BL, Christopher TA, Koch W, and Ma XL. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic Biol Med 43: 39-47, 2007. (Pubitemid 46874836)
281. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, and Min W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94: 1483-1491, 2004. (Pubitemid 38780321)
282. Zhang X, Huang B, Zhou X, and Chen C. Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method. Protein Cell 1: 675-687, 2010.
283. Zhou J, Damdimopoulos AE, Spyrou G, and Brune B. Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha. J Biol Chem 282: 7482-7490, 2007. (Pubitemid 47093694)
284. Zhou Y, Kok KH, Chun AC, Wong CM, Wu HW, Lin MC, Fung PC, Kung H, and Jin DY. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268: 921-927, 2000. (Pubitemid 30150892)